Chesterfield Royal Hospital say they were involved in some of the research which led to the discovery of a new drug to help treat covid-19, after it was revealed earlier this week that dexamethasone can cut deaths by up to a third.
Chesterfield Royal Hospital’s research team has worked with the University of Oxford in trialling this treatment as part of the research programme. 29 of the Royal's patients received this steroid treatment.
Tom Spencer, Research & Development Lead said: ”These findings and the global impact they will have are a great step forward in the fight against COVID-19. This really is a great example of the importance of research and how vital this is to improve patient care. The team are all so proud to have been a part of this trial and help find treatment options rapidly during the pandemic”
Amanda Whileman, Matron for Clinical research said ‘We are both proud and excited about these findings. For our local population to have contributed to such ground-breaking research really is incredible. I am immensely proud of what our small research team have achieved; their dedication along with the support of staff and the participation of patients has well and truly made a difference’.